2Watson H, Davidson S, Keeling D, et al. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia:Second edition[J].Britishjoumal of haematology, 2012,159( 5 ) : 528-540.
2Martel N,Lee J,Wells PS.Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis:a meta-analysis[J].Blood,2005,106(8):2710-2715.
4Greinacher A,Farner B,Kroll H,et al.Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis.A retrospective analysis of 408 patients[J].Thromb Haemost,2005,94(1):132-135.
6Warkentin TE,Roberts RS,Hirsh J,et al.Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome:a nested cohort study[J].Chest,2005,127(5):1857-1861.
7Ban-Hoefen M,Francis C.Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital[J].Thromb Res,2009,124(2):189-192.
8Mitchell C,Riley CA,Vahid B.Unusual complication of heparin-induced thrombocytopenia after mitral valve surgery:spontaneous rupture of spleen[J].Ann Thorac Surg,2007,83(3):1172-1174.
9Mattioli AV,Bonetti L,Zennaro M,et al.Heparin/PF4 antibodies formation after heparin treatment:temporal aspects and long-term follow-up[J].Am Heart J,2009,157(3):589-595.
10Everett BM,Yeh R,Foo SY,et al.Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery[J].Ann Thorac Surg,2007,83(2):592-597.
